University Hospital Erlangen publishes using MSOT: Multispectral Optoacoustic Tomography for Assessment of Crohn’s Disease Activity (New England Journal of Medicine)
iThera Medical is the leader in optoacoustic imaging (OAI) with a global customer base in preclinical and clinical research. OAI has the potential to become a widely used clinical diagnostic technique with an initial indication focus on the assessment of muscle perfusion and oxygen saturation in peripheral arterial disease and neuromuscular diseases.
The company was founded in 2010 as a spin-off of the Helmholtz Center Munich and is headquartered in Munich, Germany.
iThera Medical is the leader in optoacoustic imaging (OAI) with a global customer base in preclinical and clinical research. OAI has the potential to become a widely used clinical diagnostic technique with an initial indication focus on the assessment of muscle perfusion and oxygen saturation in peripheral arterial disease and neuromuscular diseases.
The company was founded in 2010 as a spin-off of the Helmholtz Center Munich and is headquartered in Munich, Germany.